Literature DB >> 24820637

Complex hypodiploid acute myeloid leukaemia secondary to chemotherapy for hyperdiploid multiple myeloma.

Muhajir Mohamed1, Karen Dun.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24820637     DOI: 10.1007/s12185-014-1594-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  7 in total

Review 1.  Genomics in multiple myeloma.

Authors:  Nikhil C Munshi; Hervé Avet-Loiseau
Journal:  Clin Cancer Res       Date:  2011-03-15       Impact factor: 12.531

2.  Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.

Authors:  Deepti M Reddi; Chuanyi M Lu; George Fedoriw; Yen-Chun Liu; Frances F Wang; Scott Ely; Elizabeth L Boswell; Abner Louissaint; Murat O Arcasoy; Barbara K Goodman; Endi Wang
Journal:  Am J Clin Pathol       Date:  2012-12       Impact factor: 2.493

3.  Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).

Authors:  Sham Mailankody; Ruth M Pfeiffer; Sigurdur Y Kristinsson; Neha Korde; Magnus Bjorkholm; Lynn R Goldin; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2011-07-27       Impact factor: 22.113

4.  Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics.

Authors:  Shaji Kumar; Rafael Fonseca; Rhett P Ketterling; Angela Dispenzieri; Martha Q Lacy; Morie A Gertz; Suzanne R Hayman; Francis K Buadi; David Dingli; Ryan A Knudson; Alexandra Greenberg; Stephen J Russell; Steven R Zeldenrust; John A Lust; Robert A Kyle; Leif Bergsagel; S Vincent Rajkumar
Journal:  Blood       Date:  2012-01-10       Impact factor: 22.113

5.  Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.

Authors:  W J Chng; R Santana-Dávila; S A Van Wier; G J Ahmann; S M Jalal; P L Bergsagel; M Chesi; M C Trendle; S Jacobus; E Blood; M M Oken; K Henderson; R A Kyle; M A Gertz; M Q Lacy; A Dispenzieri; P R Greipp; R Fonseca
Journal:  Leukemia       Date:  2006-05       Impact factor: 11.528

6.  Prognostic significance of copy-number alterations in multiple myeloma.

Authors:  Hervé Avet-Loiseau; Cheng Li; Florence Magrangeas; Wilfried Gouraud; Catherine Charbonnel; Jean-Luc Harousseau; Michel Attal; Gerald Marit; Claire Mathiot; Thierry Facon; Philippe Moreau; Kenneth C Anderson; Loïc Campion; Nikhil C Munshi; Stéphane Minvielle
Journal:  J Clin Oncol       Date:  2009-08-17       Impact factor: 44.544

7.  Secondary primary malignancies in multiple myeloma: an old NEMESIS revisited.

Authors:  Jay Yang; Howard R Terebelo; Jeffrey A Zonder
Journal:  Adv Hematol       Date:  2012-07-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.